SCHEMBL24254574

SCHEMBL24254574

Cc1ccc(SN(C)C)cc1C(=O)NCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.51
LMNA P02545 2/20 0.48
TSHR P16473 2/20 0.48
APEX1 P27695 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CNR1 P21554 4/20 0.42
CNR2 P34972 3/20 0.42
WDR5 P61964 1/20 0.41
EPHX2 P34913 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254576 0.85 KMT2A (0.51) APEX1MEN1KMT2A
SCHEMBL24254492 0.78 NPC1 (0.61) HPGDLMNATSHRAPEX1SMN1; SMN2
SCHEMBL26188116 0.75 EPHX2 (0.61) HPGDLMNAAPEX1ALDH1A1MEN1
SCHEMBL24254575 0.74 MAPT (0.53) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL6358333 0.70 HPGD (0.62) HPGDLMNATSHRAPEX1SMN1; SMN2
SCHEMBL11776286 0.70 TSHR (0.66) HPGDLMNATSHRAPEX1SMN1; SMN2
SCHEMBL2980187 0.69 LMNA (0.62) HPGDLMNATSHRSMN1; SMN2ALDH1A1
SCHEMBL24254520 0.69 MCL1 (0.43) HPGDTSHRALDH1A1MEN1KMT2A
SCHEMBL7616443 0.69 LMNA (0.65) HPGDLMNATSHRSMN1; SMN2ALDH1A1
SCHEMBL3169688 0.69 TSHR (0.69) HPGDLMNATSHRAPEX1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed